ENCORE PHARMA PRIVATE LIMITED
ENCORE PHARMA PRIVATE LIMITED is a UTTAR PRADESH based PRIVATE LIMITED company, Registered at dated 06-DEC-2006 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of ENCORE PHARMA PRIVATE LIMITED is U33111UP2006PTC032594 and registration number is 032594.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies KANPUR India. Authorized share capital of ENCORE PHARMA PRIVATE LIMITED is Rs. 2500000 and its paid up capital is Rs. 0. It aspire to serve in MACHINERY AND EQUIPMENTS N.E.C.MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
ENCORE PHARMA PRIVATE LIMITED has 3 directors UTTAM PANWAR, PADMAKSH GOEL, PALLAV GOEL,
The registered Email address of ENCORE PHARMA PRIVATE LIMITED is ASHISH_G91@REDIFFMAIL.COM and its registered address is 774, GANDHI COLONY MUZAFFAR NAGAR MUZAFFARNAGAR UP 251001 IN UTTAR PRADESH UTTAR PRADESH india 251001.
The current status of ENCORE PHARMA PRIVATE LIMITED shows as STRIKE OFF
COMPANY BASIC DETAILS
ENCORE PHARMA PRIVATE LIMITED
KANPUR
STRIKE OFF
MACHINERY AND EQUIPMENTS N.E.C.MANUFACTURING
U33111UP2006PTC032594
06-DEC-2006
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
2500000
CONTACT DETAILS
251001
INDIA
774, GANDHI COLONY MUZAFFAR NAGAR MUZAFFARNAGAR UP 251001 IN
ASHISH_G91@REDIFFMAIL.COM
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
00068444 | UTTAM PANWAR | Director | 06/12/2006 |
00800947 | PADMAKSH GOEL | Director | 06/12/2006 |
01214025 | PALLAV GOEL | Director | 06/12/2006 |
Details Updated by Companies
Quick Links
- All Registered company of UTTAR PRADESH
- Company Registered in UTTAR PRADESH
- All Registered company of MUZAFFARNAGAR in UTTAR PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.